Honolulu, HI, United States of America

Kent Harada


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Vaccine Development by Kent Harada

Introduction

Kent Harada is an accomplished inventor based in Honolulu, HI (US). He has made significant contributions to the field of biotechnology, particularly in vaccine development. His innovative work focuses on creating effective vaccines against flaviviral infections, which are critical for public health.

Latest Patents

Kent Harada holds a patent for a "Recombinant dimeric envelope vaccine against flaviviral infection." This invention discloses vaccines that contain a secreted recombinantly produced dimeric form of truncated flaviviral envelope protein. The vaccines are designed to elicit the production of neutralizing antibodies against flaviviruses. The dimeric forms of truncated flaviviral envelope protein are created through various methods, including linking two tandem copies of the protein and forming a leucine zipper domain. This innovative approach facilitates the production of vaccines that are easier to purify and more effective in providing protection against diseases such as dengue virus.

Career Highlights

Kent Harada is associated with Hawaii Biotechnology Group, Inc., where he continues to advance his research and development efforts. His work has led to the creation of vaccines that not only protect against infections but also provide diagnostic capabilities for individuals at risk of dengue virus infection. His contributions to the field have been recognized for their potential impact on global health.

Collaborations

Kent has collaborated with notable colleagues, including Iain D Peters and Beth-Ann G Coller. These partnerships have enhanced the research and development process, allowing for a more comprehensive approach to vaccine innovation.

Conclusion

Kent Harada's work in vaccine development exemplifies the importance of innovation in addressing public health challenges. His patented inventions are paving the way for more effective vaccines against flaviviral infections, showcasing the potential of biotechnology in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…